Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Zhou, Yujie"" wg kryterium: Autor


Tytuł :
Protective role of statins in patients with acute coronary syndrome aged ≥ 75 years with low LDL-C who underwent percutaneous coronary intervention.
Autorzy :
Bu C; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Zhao Y; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Ma H; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Han H; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Yang S; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Shi D; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Liu Y; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Fang Z; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Wang Z; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Ma Q; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Hu B; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Yang Q; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Li Y; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Liu R; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Nie B; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Zhou Y; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China .
Pokaż więcej
Źródło :
Angiology [Angiology] 2014 Aug; Vol. 65 (7), pp. 590-5. Date of Electronic Publication: 2013 Aug 28.
Typ publikacji :
Journal Article
MeSH Terms :
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/methods
Acute Coronary Syndrome/*drug therapy
Acute Coronary Syndrome/*prevention & control
Cholesterol, LDL/*metabolism
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacology
Aged ; Aged, 80 and over ; Aging ; Biomarkers/blood ; C-Reactive Protein/metabolism ; Female ; Humans ; Male
Czasopismo naukowe
Tytuł :
Effect of remote ischemic preconditioning in the elderly patients with coronary artery disease with diabetes mellitus undergoing elective drug-eluting stent implantation.
Autorzy :
Xu X; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Zhou Y; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China .
Luo S; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China Capital Medical University School of Rehabilitation Medicine, China Rehabilitation Research Centre, Beijing, China.
Zhang W; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Zhao Y; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Yu M; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Ma Q; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Gao F; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Shen H; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Zhang J; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Pokaż więcej
Źródło :
Angiology [Angiology] 2014 Sep; Vol. 65 (8), pp. 660-6. Date of Electronic Publication: 2013 Oct 24.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Complications*
Drug-Eluting Stents*
Ischemic Preconditioning*
Percutaneous Coronary Intervention*/methods
Coronary Artery Disease/*surgery
Aged ; Aged, 80 and over ; Biomarkers/analysis ; Coronary Artery Disease/complications ; Coronary Disease/complications ; Coronary Disease/surgery ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
High clopidogrel dose in patients with chronic kidney disease having clopidogrel resistance after percutaneous coronary intervention.
Autorzy :
Liang J; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China.
Wang Z; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China.
Shi D; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China.
Liu Y; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China.
Zhao Y; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China.
Han H; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China.
Li Y; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China.
Liu W; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China.
Zhang L; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China.
Yang L; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China.
Zhou Y; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China .
Pokaż więcej
Źródło :
Angiology [Angiology] 2015 Apr; Vol. 66 (4), pp. 319-25. Date of Electronic Publication: 2014 Jun 08.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Drug Resistance*
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/instrumentation
Coronary Artery Disease/*therapy
Platelet Aggregation Inhibitors/*administration & dosage
Renal Insufficiency, Chronic/*complications
Ticlopidine/*analogs & derivatives
Aged ; China ; Clopidogrel ; Coronary Artery Disease/complications ; Coronary Artery Disease/diagnosis ; Coronary Thrombosis/blood ; Coronary Thrombosis/etiology ; Coronary Thrombosis/prevention & control ; Drug Administration Schedule ; Drug-Eluting Stents ; Female ; Hemorrhage/chemically induced ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Myocardial Infarction/blood ; Myocardial Infarction/etiology ; Myocardial Infarction/prevention & control ; Platelet Aggregation/drug effects ; Platelet Aggregation Inhibitors/adverse effects ; Platelet Function Tests ; Prospective Studies ; Renal Insufficiency, Chronic/diagnosis ; Risk Factors ; Ticlopidine/administration & dosage ; Ticlopidine/adverse effects ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Percutaneous Coronary Intervention Rates and Associated Independent Predictors for Progression of Nontarget Lesions in Patients With Diabetes Mellitus After Drug-Eluting Stent Implantation.
Autorzy :
Wang L; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Zhou Y; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. .
Peng P; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Xu X; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Yang S; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Liu W; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Han H; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Jia D; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Wang J; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Ji Q; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Ge H; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Liu Y; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Shi D; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Zhao Y; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Pokaż więcej
Źródło :
Angiology [Angiology] 2016 Jan; Vol. 67 (1), pp. 12-20. Date of Electronic Publication: 2015 Apr 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus*
Drug-Eluting Stents*
Registries*
Coronary Artery Disease/*surgery
Percutaneous Coronary Intervention/*statistics & numerical data
Coronary Artery Disease/complications ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Insulin Resistance Increases the Risk of Contrast-Induced Nephropathy in Patients Undergoing Elective Coronary Intervention.
Autorzy :
Li Y; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing, China.
Liu Y; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing, China.
Shi D; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing, China.
Yang L; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing, China.
Liang J; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing, China.
Zhou Y; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing, China .
Pokaż więcej
Źródło :
Angiology [Angiology] 2016 Feb; Vol. 67 (2), pp. 139-45. Date of Electronic Publication: 2015 Apr 05.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Insulin Resistance*
Angina, Stable/*therapy
Angina, Unstable/*surgery
Contrast Media/*adverse effects
Coronary Angiography/*adverse effects
Diabetes Mellitus, Type 2/*physiopathology
Kidney/*drug effects
Kidney Diseases/*chemically induced
Percutaneous Coronary Intervention/*adverse effects
Aged ; Angina, Stable/diagnosis ; Angina, Stable/diagnostic imaging ; Angina, Unstable/diagnosis ; Angina, Unstable/diagnostic imaging ; Biomarkers/blood ; Case-Control Studies ; Chi-Square Distribution ; China/epidemiology ; Creatinine/blood ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/diagnosis ; Diabetes Mellitus, Type 2/epidemiology ; Female ; Glomerular Filtration Rate/drug effects ; Humans ; Incidence ; Kidney/physiopathology ; Kidney Diseases/blood ; Kidney Diseases/diagnosis ; Kidney Diseases/epidemiology ; Kidney Diseases/physiopathology ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Odds Ratio ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Women With Early Menopause Have Higher Rates of Target Lesion Revascularization After Percutaneous Coronary Intervention.
Autorzy :
Zhang L; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Wang Z; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Liu X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Zhou Z; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Zhao Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Shi D; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Liu Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Liang J; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Yang L; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Chai M; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Zhou Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China .
Pokaż więcej
Źródło :
Angiology [Angiology] 2016 Apr; Vol. 67 (4), pp. 311-6. Date of Electronic Publication: 2015 Jun 01.
Typ publikacji :
Journal Article
MeSH Terms :
Menopause/*physiology
Percutaneous Coronary Intervention/*adverse effects
Adult ; Age Factors ; Aged ; Aged, 80 and over ; Coronary Artery Disease/complications ; Female ; Humans ; Middle Aged ; Myocardial Infarction/etiology ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Invasive Management Strategies and Antithrombotic Treatments in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome in China: Findings From the Improving CCC Project (Care for Cardiovascular Disease in China).
Autorzy :
Yang Q; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Wang Y; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Liu J; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Liu J; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Hao Y; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Smith SC Jr; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Huo Y; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Fonarow GC; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Ma C; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Ge J; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Taubert KA; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Morgan L; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Guo Y; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Wang W; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Zhou Y; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Zhao D; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). .
Pokaż więcej
Corporate Authors :
CCC-ACS Investigators
Źródło :
Circulation. Cardiovascular interventions [Circ Cardiovasc Interv] 2017 Jun; Vol. 10 (6).
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/mortality
Percutaneous Coronary Intervention*/standards
Acute Coronary Syndrome/*therapy
Anticoagulants/*administration & dosage
Fibrinolytic Agents/*administration & dosage
Non-ST Elevated Myocardial Infarction/*therapy
Platelet Aggregation Inhibitors/*administration & dosage
Acute Coronary Syndrome/blood ; Acute Coronary Syndrome/diagnosis ; Aged ; Aged, 80 and over ; Anticoagulants/adverse effects ; China ; Clinical Decision-Making ; Coronary Angiography ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; Fibrinolytic Agents/adverse effects ; Guideline Adherence ; Humans ; Male ; Middle Aged ; Non-ST Elevated Myocardial Infarction/blood ; Non-ST Elevated Myocardial Infarction/diagnosis ; Platelet Aggregation Inhibitors/adverse effects ; Practice Guidelines as Topic ; Practice Patterns, Physicians' ; Registries ; Risk Assessment ; Risk Factors ; Time Factors ; Time-to-Treatment ; Treatment Outcome
Czasopismo naukowe
Tytuł :
CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis.
Autorzy :
Xi Z; a Department of Cardiology , Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease , Beijing , China.
Fang F; b Sleep Center , Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease , Beijing , China.
Wang J; a Department of Cardiology , Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease , Beijing , China.
AlHelal J; c International School of Capital Medical University , Beijing , China.
Zhou Y; a Department of Cardiology , Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease , Beijing , China.
Liu W; a Department of Cardiology , Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease , Beijing , China.
Pokaż więcej
Źródło :
Platelets [Platelets] 2019; Vol. 30 (2), pp. 229-240. Date of Electronic Publication: 2017 Dec 19.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Clopidogrel/*therapeutic use
Coronary Artery Disease/*etiology
Cytochrome P-450 CYP2C19/*genetics
Percutaneous Coronary Intervention/*adverse effects
Aged ; Asian Continental Ancestry Group ; Clopidogrel/pharmacology ; Coronary Artery Disease/pathology ; Female ; Genotype ; Humans ; Male ; Middle Aged ; Percutaneous Coronary Intervention/methods
Czasopismo naukowe
Tytuł :
Safety and efficacy of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: One-year results from a prospective patient-level pooled analysis of NeoVas trials.
Autorzy :
Xu K; General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Fu G; Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Xu B; State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Centre for Coronary Heart Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhou Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Su X; Department of Cardiology, Wuhan Asia Heart Hospital, Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China.
Liu H; Department of Cardiology, Chinese Armed Police Force General Hospital, Beijing, China.
Zhang Z; Department of Cardiology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Yu B; Department of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
Wang X; General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Han Y; General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Pokaż więcej
Corporate Authors :
NeoVas OPC Investigators
Źródło :
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2019 Feb 15; Vol. 93 (S1), pp. 832-838.
Typ publikacji :
Journal Article
MeSH Terms :
Absorbable Implants*
Coated Materials, Biocompatible*
Acute Coronary Syndrome/*therapy
Cardiovascular Agents/*administration & dosage
Coronary Artery Disease/*therapy
Percutaneous Coronary Intervention/*instrumentation
Sirolimus/*administration & dosage
Acute Coronary Syndrome/diagnostic imaging ; Acute Coronary Syndrome/mortality ; Adolescent ; Adult ; Aged ; Cardiovascular Agents/adverse effects ; China ; Coronary Artery Disease/diagnostic imaging ; Coronary Artery Disease/mortality ; Female ; Humans ; Male ; Middle Aged ; Myocardial Infarction/epidemiology ; Percutaneous Coronary Intervention/adverse effects ; Percutaneous Coronary Intervention/mortality ; Prospective Studies ; Prosthesis Design ; Randomized Controlled Trials as Topic ; Registries ; Risk Factors ; Sirolimus/adverse effects ; Time Factors ; Treatment Outcome ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies